Welcome to resTORbio

resTORbio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.

The decline in immune function that occurs during aging, or immunosenescence, increases susceptibility to a variety of diseases that significantly contribute to morbidity and mortality in the elderly. resTORbio’s lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies. resTORbio's approach focuses on the mechanistic target of rapamycin (mTOR) pathway, an evolutionarily conserved pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1, or TORC1. The Company's initial focus is on the development of RTB101, an orally administered, small molecule, potent TORC1 inhibitor, alone and in combination with other mTOR inhibitors such as everolimus, as a first-in-class immunotherapy program designed to improve immune function. The lead indication for the program is the reduction of incidence of respiratory tract infections, or RTIs, in the elderly regardless of the causative pathogen.

 
 

resTORbio's goal is to be a leading biopharmaceutical company focused on treating aging-related diseases.

 

Our Key Shareholders

 
 

 

Our Team

 
Chen_Schor.png

Chen Schor
Co-Founder, President and CEO

 
Abdellah.png

Abdellah Sentissi, Ph.D
Head of CMC and Pharmaceutical Development (Contractor)

Joan_Mannick.png

Joan Mannick, M.D.
Co-Founder, Chief Medical Officer

 
Karen-Jauregui.png

Karen Jauregui
Vice President of Regulatory Affairs

Sarb_Shergill.png

Sarb Shergill, Ph.D.
Vice President of Clinical Operations

 
John_McCabe.png

John McCabe
Vice President of Finance

 
Chen_Schor.png

Chen Schor
Board of Directors

 
Daphne_Zohar.png

Daphne Zohar
Board of Directors

Jonathan-Silverstein.png

Jonathan Silverstein, J.D.
Board of Directors

 
David_Steinburg.png

David Steinberg
Board of Directors

Paul-Fonteyne.png

Paul Fonteyne
Board of Directors

 
LynneSullivan.png

Lynne Sullivan
Board of Directors

 
Hayden-8.png

Frederick G. Hayden, M.D.
Clinical Advisory Board Member

Johnston-8.png

Sebastian L. Johnston, Ph.D.
Clinical Advisory Board Member

 
Whitley-8.png

Richard Whitley, M.D.
Clinical Advisory Board Member

McElhaney-8.png

Janet McElhaney, M.D.
Clinical Advisory Board Member